Pay in 4 interest-free payments of $6.23 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Diao L, Meibohm B
The product is intended exclusively for scientific investigation and should remain within controlled research environments at all times
P-LLY Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements (as that term is defined in the Private Securities Litigation Reform Act of 1995) about orforglipron as a potential treatment for adults with type 2 diabetes, and the timeline for regulatory submissions and actions, future readouts, presentations, and other milestones relating to orforglipron and its clinical trials and reflects Lilly's current beliefs and expectations
There was a one-week interval between each testing condition (drug or control treatment)
If one cooler fails, the other remains viable
